NMO trials

Principal Investigator: Larry Cook
Keywords: NMO Department: Pediatric Critical Care
IRB Number: 00064796 Co Investigator:  
Specialty: Neurology, Neurology, Neurology
Sub Specialties: Neuromuscular Diseases, Multiple Sclerosis,
Recruitment Status: Active, not recruiting

Contact Information

Larry Cook
Larry.Cook@hsc.utah.edu
801-585-9760

Brief Summary

We have been funded to function as the Data Coordinating Center (DCC) for the Guthy Jackson Charitable Foundation (GJCF). This IRB is for funding received from the GJCF and not for a specific study. This DCC has been established by the GJCF for Neuromyelitis Optica (NMO) and NMO spectrum diseases research (observational studies and clinical trials).

NMO stands for neuromyelitis optica, originally known as Devic’s Disease. NMO is currently an incurable but treatable autoimmune disorder. The body’s immune system attacks its own healthy cells, most commonly in the optic nerves and spinal cord. It can cause temporary or permanent blindness and/or paralysis, and may have periods of remission and relapse.

GJCF will be engaged in multi-center observational studies and clinical trials concerning the care of children, adolescents, and adults with NMO and NMO spectrum diseases. All studies will be approved by the Guthy Jackson Charitable Foundation and the IRB of each Clinical Center. Funding for this began February 2013.
 

This is an “umbrella” application for the Data Coordinating Center (DCC) activities.

Inclusion Criteria

As this is an umbrella application for the Data Coordinating Center (DCC) activities, inclusion criteria are specified in each respective study.

Exclusion Criteria

As this is an umbrella application for the Data Coordinating Center (DCC) activities, exclusion criteria are specified in each respective study.